Trial Profile
Study for Apatinib Combined With TILA-TACE in hepatocellular carcinoma with pulmonary metastasis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 16 Oct 2018 New trial record